Fighting TB with Hope: Stories of Stigma and Strength from Three Generations in Mumbai, India
March 24, 2022From a seven-year-old child to a mother of two children, drug-resistant tuberculosis is rampant among all age groups. Globally, TB is the leading killer among infectious diseases. One-third of these deaths occurred in India. Patients either do not receive timely,...
Read moreTuberculosis: MSF responds to updated WHO guidelines for tuberculosis in children
March 21, 2022The deadly tuberculosis diagnostic gap in children remains a major challenge Geneva – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the updated World Health Organization (WHO) guidelines for the management of tuberculosis (TB) in children and adolescents, which provide recommendations...
Read moreTuberculosis: Clinical trial results offer hope to DR-TB patients with short, effective treatment
October 20, 2021LONDON – TB-PRACTECAL, a clinical trial led by Doctors Without Borders/Médecins Sans Frontières (MSF), has found that a new, all-oral, six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) [1] than the currently accepted standard of care....
Read moreTuberculosis: EndTB clinical trial for multidrug-resistant TB completes enrolment
October 18, 2021BOSTON/PARIS — Hundreds of patient volunteers from four continents have enrolled in a trial that aims to find safer, shorter, and effective treatments for multidrug-resistant tuberculosis (MDR-TB), an airborne, infectious disease that has grown resistant to standard medications. A group of scientists and...
Read moreUkraine: Fighting tuberculosis with medication, mental health and social support
September 21, 2021In Zhytomyr, Ukraine, our teams works with the Regional TB Dispensary to treat patients who have drug-resistant forms of tuberculosis (DR-TB). They are treated with a short course of DR-TB medication and the possibility of being treated at home most of the...
Read moreAccess to Medicines: Lifesaving TB medicines still out of reach for children in high-burden countries
September 3, 2021Geneva - The World Health Organization (WHO) recently released new rapid guidance recommending that children of all ages with drug-resistant tuberculosis (DR-TB) have access to all-oral treatment using the drugs bedaquiline and/or delamanid. However, adopting these new recommendations in high TB...
Read moreCOVID-19 in India: Tackling tuberculosis in the middle of coronavirus pandemic
May 9, 2021By Aparna Iyer, Project Medical Referent, MSF Drug-Resistant Tuberculosis Project in MumbaiMSF’s drug-resistant tuberculosis (DR-TB) and HIV project is located in the M-East Ward, one of the TB high-burden areas in Mumbai. During the second wave, there was a high...
Read moreTuberculosis: Sustainable solutions for children and adolescents at risk of drug-resistant TB
March 24, 2021They walked in single file through the narrow alleyways, winding away from their tin shack in Cape Town towards the health centre. Keitu – just 11 years old – carried her baby brother on her back since their mother was...
Read moreTuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
March 24, 2021LONDON - A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more...
Read moreStep UP For TB: Report shows new tests and drugs for world’s deadliest infectious disease remain out of reach
November 16, 2020MSF calls on governments and donors to step up and speed up TB testing and treatmentGeneva — As the COVID-19 pandemic threatens to derail the global response to tuberculosis (TB), Doctors Without Borders/Médecins Sans Frontières (MSF) called on governments to...
Read moreHamari Awaaz: Addressing stigma in people living with multidrug-resistant tuberculosis in India
October 23, 2020[3d-flip-book mode="fullscreen" id="21871"][/3d-flip-book]
Read moreendTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India
October 22, 2020Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...
Read more